Harmony Biosciences Holdings, Inc.Harmony Biosciences Holdings, Inc.Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc.

No trades
See on Supercharts

HRMY fundamentals

Harmony Biosciences Holdings, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of HRMY for the last quarter is 154.62 M USD, and it's 8.19% lower compared to the previous quarter. The net income of Q1 24 is 38.33 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth